Option Care Health’s (OPCH) “Market Outperform” Rating Reaffirmed at JMP Securities

JMP Securities reissued their market outperform rating on shares of Option Care Health (NASDAQ:OPCH) in a report issued on Friday morning,Benzinga reports. JMP Securities currently has a $30.00 price objective on the stock, down from their prior price objective of $31.00.

Several other equities analysts also recently commented on OPCH. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their target price for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Truist Financial decreased their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. UBS Group started coverage on Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective for the company. Barrington Research decreased their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. Finally, The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $29.14.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $23.99 on Friday. The stock has a 50-day moving average price of $23.10 and a 200 day moving average price of $27.70. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health has a 12-month low of $21.39 and a 12-month high of $34.63. The stock has a market capitalization of $4.08 billion, a P/E ratio of 20.16, a P/E/G ratio of 2.43 and a beta of 1.31.

Insider Buying and Selling at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the stock in a transaction dated Friday, November 8th. The stock was purchased at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Hedge funds have recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its stake in Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after acquiring an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its holdings in Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after acquiring an additional 1,446 shares during the period. International Assets Investment Management LLC grew its position in Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after acquiring an additional 2,757 shares during the last quarter. Finally, Quarry LP lifted its position in shares of Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after purchasing an additional 2,628 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.